Literature DB >> 3357723

Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection.

M G Brunette1, L Lands, L P Thibodeau.   

Abstract

In this study, the potential for short courses of glucocorticoids to prevent or reduce the severity of asthma induced by viral respiratory infections in preschool children was investigated. Two groups of children with a mean age of 36.4 +/- 3.9 months and 40.4 +/- 4.9 months were monitored during a 2-year period. Group 1, considered as the control group, received theophylline preparations and orciprenaline either on a continuous basis or during attacks. During severe attacks, albuterol was administered by nebulization, with corticosteroids occasionally added for seven to 14 days in cases of poor response to albuterol. Group 2 received the same treatment during the first year. During the second year, however, a short-term course of prednisone (1 mg/kg) was given as soon as the first symptoms of an upper respiratory tract infection appeared, prior to any signs of wheezing. Results indicate that, whereas morbidity remained constant in the control group during the 2-year observation period, a significant decrease in the number of wheezing days (65%), attacks (56%), visits to the emergency room (61%), and hospitalizations (90%) occurred in group 2. It was concluded that preschool children who suffer from repeated asthma attacks related to upper respiratory tract infections may benefit greatly from the preventive administration of corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3357723

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

Review 1.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

Review 2.  The economic aspects of drug delivery in asthma.

Authors:  R J Massie; C M Mellis
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

3.  Pharmacotherapy--treatment of intermittent asthma with ICSs.

Authors: 
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

Review 4.  [Childhood asthma and viral infection: interactions and therapeutic possibilities].

Authors:  M Boquete; F Carballada
Journal:  Allergol Immunopathol (Madr)       Date:  2001 May-Jun       Impact factor: 1.667

Review 5.  Treatment of chronic asthma in children: the changing role of inhaled corticosteroids. Allergy Section, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1991-09-15       Impact factor: 8.262

6.  Treatment of Severe Acute Asthma is Damage Control.

Authors:  Miles Weinberger
Journal:  J Pediatr Pharmacol Ther       Date:  2013-04

Review 7.  Canadian consensus on the treatment of asthma in children. Toronto, September, 1990.

Authors:  H Levison
Journal:  CMAJ       Date:  1991-12-01       Impact factor: 8.262

Review 8.  The cost of asthma: can it be reduced?

Authors:  C M Mellis; J K Peat; A J Woolcock
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

9.  Viral respiratory infection and the link to asthma.

Authors:  James E Gern
Journal:  Pediatr Infect Dis J       Date:  2008-10       Impact factor: 2.129

Review 10.  Association of rhinovirus infections with asthma.

Authors:  J E Gern; W W Busse
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.